<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>LegalNewsWatch &#187; Zyprexa</title>
	<atom:link href="http://www.legalnewswatch.com/tags/zyprexa/feed" rel="self" type="application/rss+xml" />
	<link>http://www.legalnewswatch.com</link>
	<description>Stories That Impact Your Rights</description>
	<lastBuildDate>Thu, 16 Jul 2009 02:38:59 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Zyprexa Lawsuits: Lilly Agrees to Settle Most Claims</title>
		<link>http://www.legalnewswatch.com/638/zyprexa-lawsuits-lilly-agrees-to-settle-most-claims</link>
		<comments>http://www.legalnewswatch.com/638/zyprexa-lawsuits-lilly-agrees-to-settle-most-claims#comments</comments>
		<pubDate>Fri, 05 Jan 2007 20:04:04 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/638/zyprexa-lawsuits-lilly-agrees-to-settle-most-claims</guid>
		<description><![CDATA[Eli Lilly and Co. said on Thursday it has agreed to pay up to $500 million to settle 18,000 Zyprexa lawsuits alleging it had failed to adequately warn patients that Zyprexa may increase the risk of diabetes.
&#8220;While we remain confident that these claims are without merit, we took this difficult step because we believe it [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/638/zyprexa-lawsuits-lilly-agrees-to-settle-most-claims/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lilly Subpoenaed for Documents Relating to Sales of Zyprexa</title>
		<link>http://www.legalnewswatch.com/610/lilly-subpoenaed-for-documents-relating-to-sales-of-zyprexa</link>
		<comments>http://www.legalnewswatch.com/610/lilly-subpoenaed-for-documents-relating-to-sales-of-zyprexa#comments</comments>
		<pubDate>Fri, 12 Aug 2005 22:40:57 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=610</guid>
		<description><![CDATA[In June 2005, Eli Lilly and company received a subpoena from Florida attorney generalï¿½s office seeking documents on Medicaid-related sales of the companyï¿½s Zyprexa and its marketing and promotional practices with respect to the schizophrenia drug. The subpoena came from the Medicaid Fraud Control unit of the state attorney generalï¿½s office, the company said in [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/610/lilly-subpoenaed-for-documents-relating-to-sales-of-zyprexa/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Lilly Agrees to Pay $690M to Settle Zyprexa Class Action Lawsuits</title>
		<link>http://www.legalnewswatch.com/601/lilly-agrees-to-pay-690m-to-settle-zyprexa-class-action-lawsuits</link>
		<comments>http://www.legalnewswatch.com/601/lilly-agrees-to-pay-690m-to-settle-zyprexa-class-action-lawsuits#comments</comments>
		<pubDate>Thu, 16 Jun 2005 06:02:58 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=601</guid>
		<description><![CDATA[Eli Lilly &#38; Co. said it has agreed to pay $690 million to settle about 8,000 Zyprexa lawsuits pending in the United States, over its alleged failure to provide adequate warning that the drug could increase a patients&#8217; risk for developing diabetes.
&#8220;While we believe the claims are without merit, we took this difficult step because [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/601/lilly-agrees-to-pay-690m-to-settle-zyprexa-class-action-lawsuits/feed</wfw:commentRss>
		<slash:comments>17</slash:comments>
		</item>
		<item>
		<title>Canadian Class Action Lawsuit Claims Zyprexa Causes Diabetes</title>
		<link>http://www.legalnewswatch.com/539/canadian-class-action-lawsuit-claims-zyprexa-causes-diabetes</link>
		<comments>http://www.legalnewswatch.com/539/canadian-class-action-lawsuit-claims-zyprexa-causes-diabetes#comments</comments>
		<pubDate>Thu, 03 Feb 2005 02:16:17 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=539</guid>
		<description><![CDATA[A British Columbia man last week filed a class action lawsuit against drug maker Eli Lilly, alleging the company &#8220;purposefully minimized and understated health hazards and risks associated with Zyprexa.&#8221;
The Plaintiff alleges that his use of Zyprexa resulted in diabetes.
&#8220;Eli Lilly, through literature and oral statements, deceived potential users of Zyprexa and their physicians by [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/539/canadian-class-action-lawsuit-claims-zyprexa-causes-diabetes/feed</wfw:commentRss>
		<slash:comments>6</slash:comments>
		</item>
		<item>
		<title>Florida Medicaid Limits Coverage on Neurontin, Zyprexa and Vioxx</title>
		<link>http://www.legalnewswatch.com/404/florida-medicaid-limits-coverage-on-neurontin-zyprexa-and-vioxx</link>
		<comments>http://www.legalnewswatch.com/404/florida-medicaid-limits-coverage-on-neurontin-zyprexa-and-vioxx#comments</comments>
		<pubDate>Thu, 05 Aug 2004 18:59:13 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Neurontin]]></category>
		<category><![CDATA[Vioxx]]></category>
		<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=404</guid>
		<description><![CDATA[Florida Medicaid&#8217;s new policy will no longer pay for Neurontin, Zyprexa and so-called COX II pain relievers Celebrex, Vioxx and Bextra unless they are prescribed as listed on the U.S. Food and Drug Administration label, the Sun Sentinel reports.
The new policy ends coverage for many &#8220;off-label&#8221; uses, uses not approved by the FDA, forcing thousands [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/404/florida-medicaid-limits-coverage-on-neurontin-zyprexa-and-vioxx/feed</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Zyprexa Lawsuits to be Unified in New York</title>
		<link>http://www.legalnewswatch.com/355/zyprexa-lawsuits-to-be-unified-in-new-york</link>
		<comments>http://www.legalnewswatch.com/355/zyprexa-lawsuits-to-be-unified-in-new-york#comments</comments>
		<pubDate>Tue, 04 May 2004 17:20:56 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=355</guid>
		<description><![CDATA[Zyprexa Lawsuits against Eli Lilly and Co. over its blockbuster drug are headed to court in Brooklyn, N.Y.  
Lilly&#8217;s request to consolidate a growing number of Zyprexa cases in Indiana was denied by a judicial panel on multidistrict litigation in April.
&#8220;Obviously we don&#8217;t like going to the defendant&#8217;s home state&#8221; to try the Zyprexa [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/355/zyprexa-lawsuits-to-be-unified-in-new-york/feed</wfw:commentRss>
		<slash:comments>23</slash:comments>
		</item>
		<item>
		<title>Zyprexa Class Action Lawsuit Filed Against Eli Lilly and Company</title>
		<link>http://www.legalnewswatch.com/347/zyprexa-class-action-lawsuit-filed-against-eli-lilly-and-company</link>
		<comments>http://www.legalnewswatch.com/347/zyprexa-class-action-lawsuit-filed-against-eli-lilly-and-company#comments</comments>
		<pubDate>Tue, 20 Apr 2004 15:41:11 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=347</guid>
		<description><![CDATA[Parker &#38; Waichman, LLP and Douglas &#38; London LLP Monday announced the first nationwide class action lawsuit against Eli Lilly and Company on behalf of all persons residing in the United States who used the atypical antipsychotic drug Zyprexa.
The lawsuit, filed in the U.S. District Court for the Eastern District of New York, seeks relief [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/347/zyprexa-class-action-lawsuit-filed-against-eli-lilly-and-company/feed</wfw:commentRss>
		<slash:comments>15</slash:comments>
		</item>
		<item>
		<title>U.S. Officials Probe Marketing of Zyprexa, Prozac and Evista</title>
		<link>http://www.legalnewswatch.com/338/us-officials-probe-marketing-of-zyprexa-prozac-and-evista</link>
		<comments>http://www.legalnewswatch.com/338/us-officials-probe-marketing-of-zyprexa-prozac-and-evista#comments</comments>
		<pubDate>Sun, 28 Mar 2004 02:26:09 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Prozac]]></category>
		<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=338</guid>
		<description><![CDATA[Eli Lilly and Co. said yesterday the U.S. Attorney&#8217;s Office in Pennsylvania is investigating its marketing and promotional practices of certain drugs.
The company said it believes the drugs involved include its schizophrenia drug Zyprexa, its former blockbuster antidepressant drug Prozac, and its osteoporosis drug Evista.
The Indianapolis drug maker said it the outcome of the investigation [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/338/us-officials-probe-marketing-of-zyprexa-prozac-and-evista/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Parker &amp; Waichman Files Lawsuits Against Lilly Over Zyprexa</title>
		<link>http://www.legalnewswatch.com/337/parker-waichman-files-lawsuits-against-lilly-over-zyprexa</link>
		<comments>http://www.legalnewswatch.com/337/parker-waichman-files-lawsuits-against-lilly-over-zyprexa#comments</comments>
		<pubDate>Fri, 26 Mar 2004 20:42:11 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=337</guid>
		<description><![CDATA[Parker &#38; Waichman LLP said last week it filed multiple lawsuits against Eli Lilly and Company on behalf of three individuals who claim to have sustained severe side effects from taking the schizophrenia drug Zyprexa.
The firm said two of the plaintiffs have been diagnosed with serious cases of diabetes, and another plaintiff has required lengthy [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/337/parker-waichman-files-lawsuits-against-lilly-over-zyprexa/feed</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>FDA: Atypical Antipsychotic Drugs May Increase Diabetes Risk</title>
		<link>http://www.legalnewswatch.com/268/fda-atypical-antipsychotic-drugs-may-increase-diabetes-risk</link>
		<comments>http://www.legalnewswatch.com/268/fda-atypical-antipsychotic-drugs-may-increase-diabetes-risk#comments</comments>
		<pubDate>Mon, 22 Sep 2003 17:52:51 +0000</pubDate>
		<dc:creator>Mario Lozano</dc:creator>
				<category><![CDATA[Geodon]]></category>
		<category><![CDATA[Risperdal]]></category>
		<category><![CDATA[Seroquel]]></category>
		<category><![CDATA[Zyprexa]]></category>

		<guid isPermaLink="false">http://www.legalnewswatch.com/?p=268</guid>
		<description><![CDATA[The U.S. Food and Drug Administration has asked the makers of six atypical antipsychotic drugs to update product labeling to include a warning about a possible link with diabetes, The Associated Press reported. The atypical antipsychotic drugs includes Zyprexa by Eli Lilly &#38; Co., Clozaril by Novartis, Risperdal by Janssen, Seroquel by AstraZeneca, Geodon by [...]]]></description>
		<wfw:commentRss>http://www.legalnewswatch.com/268/fda-atypical-antipsychotic-drugs-may-increase-diabetes-risk/feed</wfw:commentRss>
		<slash:comments>5</slash:comments>
		</item>
	</channel>
</rss>
